New ATS Community-acquired Pneumonia Guideline Summary
- Amanda Galiano, PharmD, MSHI
- Sep 8
- 1 min read
There is a little controversy with this one. The guideline does go into more details about who would benefit most from corticosteroids (ICU patients, patients with elevated inflammatory markers), and viral co-infection rates (I think we'll get a deeper dive into that when IDSA publishes their letter). These are just my cliffnotes for the 100 page document (links in comment).
